End-of-day quote
Shenzhen S.E.
06:00:00 2024-05-16 pm EDT
|
5-day change
|
1st Jan Change
|
6.27
CNY
|
+0.97%
|
|
-4.27%
|
-17.93%
|
Fiscal Period: December |
2019
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
3,651
|
4,648
|
6,781
|
3,551
|
2,914
|
-
|
Enterprise Value (EV)
1 |
3,651
|
4,648
|
6,781
|
3,551
|
2,914
|
2,914
|
P/E ratio
|
24.5
x
|
21.8
x
|
-
|
-
|
-
|
-
|
Yield
|
1.09%
|
-
|
1.51%
|
-
|
-
|
-
|
Capitalization / Revenue
|
2.33
x
|
-
|
2.28
x
|
1.49
x
|
0.81
x
|
0.68
x
|
EV / Revenue
|
2.33
x
|
-
|
2.28
x
|
1.49
x
|
0.81
x
|
0.68
x
|
EV / EBITDA
|
-
|
-
|
-
|
8.58
x
|
3.73
x
|
3.11
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
2.85
x
|
-
|
3.31
x
|
1.64
x
|
1.07
x
|
0.92
x
|
Nbr of stocks (in thousands)
|
445,601
|
465,785
|
465,089
|
464,756
|
464,756
|
-
|
Reference price
2 |
8.193
|
9.978
|
14.58
|
7.640
|
6.270
|
6.270
|
Announcement Date
|
2/27/20
|
3/30/22
|
3/29/23
|
3/29/24
|
-
|
-
|
Fiscal Period: December |
2019
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
1,569
|
-
|
2,970
|
2,390
|
3,616
|
4,280
|
EBITDA
1 |
-
|
-
|
-
|
413.8
|
781
|
936
|
EBIT
1 |
180
|
-
|
-
|
215.1
|
548
|
691
|
Operating Margin
|
11.47%
|
-
|
-
|
9%
|
15.15%
|
16.14%
|
Earnings before Tax (EBT)
|
173.7
|
-
|
-
|
-
|
-
|
-
|
Net income
|
149.8
|
213.6
|
-
|
-
|
-
|
-
|
Net margin
|
9.54%
|
-
|
-
|
-
|
-
|
-
|
EPS
|
0.3348
|
0.4578
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
0.0889
|
-
|
0.2200
|
-
|
-
|
-
|
Announcement Date
|
2/27/20
|
3/30/22
|
3/29/23
|
3/29/24
|
-
|
-
|
Fiscal Period: December |
2022 Q4
|
2023 Q1
|
---|
Net sales
1 |
804.7
|
742.2
|
EBITDA
|
-
|
-
|
EBIT
|
-
|
-
|
Operating Margin
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
Net income
|
-
|
-
|
Net margin
|
-
|
-
|
EPS
|
-
|
-
|
Dividend per Share
|
-
|
-
|
Announcement Date
|
3/29/23
|
4/26/23
|
Fiscal Period: December |
2019
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
12.2%
|
-
|
23%
|
9.24%
|
17.4%
|
18.8%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
11.7%
|
4.85%
|
9.4%
|
11.1%
|
Assets
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
1 |
2.880
|
-
|
4.400
|
4.660
|
5.860
|
6.850
|
Cash Flow per Share
|
0.5700
|
-
|
1.110
|
-
|
-
|
-
|
Capex
2 |
155
|
-
|
-
|
349
|
156
|
164
|
Capex / Sales
|
9.85%
|
-
|
-
|
14.61%
|
4.31%
|
3.83%
|
Announcement Date
|
2/27/20
|
3/30/22
|
3/29/23
|
3/29/24
|
-
|
-
|
Last Close Price
6.27
CNY Average target price
15
CNY Spread / Average Target +139.23% Consensus |
1st Jan change
|
Capi.
|
---|
| -17.93% | 400M | | +2.08% | 3.61B | | -19.91% | 2.15B | | -7.20% | 1.95B | | +2.34% | 1.9B | | +1.54% | 1.71B | | -3.83% | 1.3B | | +3.39% | 1.19B | | -18.55% | 1.06B | | +2.18% | 1.06B |
Pesticide
|